-
Sort By
-
Newest
-
Newest
-
Oldest
-
All Categories
-
All Categories
-
Alternatives
-
ASX
-
Crypto
-
ESG
-
ETFs
-
Global
-
Growth
-
IPO
-
M&A
-
Small caps
-
Unlisted Assets
-
Value
With women living longer than men on average, it’s often forgotten that almost half the intergenerational transfer won’t even be intergenerational – it will be horizontal or intra-generational because it will be passed on to spouses.
A UK research report has found a growing number of couples over 60 live in separate households, a trend particularly pronounced among those entering a new relationship at this stage of their lives. Improved mental health is a bonus.
A mild warning to the market from this global travel group in October had skittish investors bailing out. Those who held their nerve could enjoy a higher payout and share price if the travel industry picks up in 2025.
The micro fund manager reported a solid performance with increasing funds under management, revenue and active customers. On the sharemarket, investors have been finding some appetite for this stock, but it’s a far cry from the buying frenzy that took it to $2 in 2021.
To tackle the mental illness and social isolation that can tragically accompany ageing, six AI characters have been recruited to offer patience, empathy, knowledge and friendly encouragement to those suffering.
The Australian Energy Market Commission insists consumers are protected in its final ruling. The National Seniors Association begs to differ, arguing these changes will punish those who don’t understand how to change their energy use.
With Australia in the early stages of a $3.5 trillion wealth transfer, there are significant opportunities for charities to benefit. Luckily for them, a growing number of families agree that their wealth should be more equitably shared.
The biotech giant is poised for a strong performance, building on a solid set of numbers posted in 2024. The wildcard remains a Donald Trump presidency and the potential for disruptive economic policies.
Australia’s largest private healthcare provider is growing turnover, making a profit and rewarding shareholders. It’s still failing to impress a sharemarket that is constantly being reminded of the sector’s poor health.
The Big Australian will have to navigate the inevitable tensions between Beijing and the White House over the next four years. A strong cash flow and rising demand for some its key commodities such as copper and potash will make its task easier.
The first quarter of 2024-25 saw the largest supermarket player grow its sales. This positive result was more than offset by a combination of regulatory and political factors, higher operating costs and growing competition from Amazon.
Investment in technology, strengthening infrastructure, expanding product offerings and acquisitions are underpinning this financial services company’s strong earnings performance – and investors are lapping it up.